Previous genome-wide association studies (GWASs) have shown that common genetic variation contributes to the heritable risk of glioma. To identify new glioma susceptibility loci, we conducted a meta-analysis of four GWAS (totalling 4, 147 cases and 7, 435 controls),with imputation using 1000 Genomes and UK10K Project data as reference. After genotyping an additional 1, 490 cases and 1, 723 controls we identify new risk loci for glioblastoma (GBM) at 12q23.33 (rs3851634, near POLR3B, P = 3.02 x 10(-9)) and non-GBM at 10q25.2 (rs11196067, near VTI1A, P = 4.32 x 10(-8)),11q23.2 (rs648044, near ZBTB16, P = 6.26 x 10(-11)),12q21.2 (rs12230172, P = 7.53 x 10(-11)) and 15q24.2 (rs1801591, near ETFA, P = 5.71 x 10(-9)). Our findings provide further...
Genomewide association studies (GWAS) and candidate-gene studies have implicated single-nucleotide p...
Recent genome-wide association studies of glioma have led to the discovery of single nucleotide poly...
To identify protein-altering variants (PAVs) for glioma, we analysed Illumina HumanExome BeadChip ex...
Previous genome-wide association studies (GWASs) have shown that common genetic variation contribute...
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, ...
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, ...
Previous genome-wide association studies (GWASs) have shown that common genetic variation contribute...
To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide association st...
Genome-wide association studies (GWAS) have successfully identified a number of common single-nucleo...
Genome-wide association studies (GWAS) have so far identified 25 loci associated with glioma risk, w...
Since the first reports in 2009, genome-wide association studies (GWAS) have been successful in iden...
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, ...
To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide association st...
Genome-wide association studies (GWAS) have successfully identified a number of common single-nucleo...
Background The aetiology of glioma is poorly understood. Summary data from genome-wide association s...
Genomewide association studies (GWAS) and candidate-gene studies have implicated single-nucleotide p...
Recent genome-wide association studies of glioma have led to the discovery of single nucleotide poly...
To identify protein-altering variants (PAVs) for glioma, we analysed Illumina HumanExome BeadChip ex...
Previous genome-wide association studies (GWASs) have shown that common genetic variation contribute...
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, ...
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, ...
Previous genome-wide association studies (GWASs) have shown that common genetic variation contribute...
To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide association st...
Genome-wide association studies (GWAS) have successfully identified a number of common single-nucleo...
Genome-wide association studies (GWAS) have so far identified 25 loci associated with glioma risk, w...
Since the first reports in 2009, genome-wide association studies (GWAS) have been successful in iden...
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, ...
To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide association st...
Genome-wide association studies (GWAS) have successfully identified a number of common single-nucleo...
Background The aetiology of glioma is poorly understood. Summary data from genome-wide association s...
Genomewide association studies (GWAS) and candidate-gene studies have implicated single-nucleotide p...
Recent genome-wide association studies of glioma have led to the discovery of single nucleotide poly...
To identify protein-altering variants (PAVs) for glioma, we analysed Illumina HumanExome BeadChip ex...